Cost-utility of respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for disease prevention among colombian infants

Jaime Ordóñez, Beatriz Ospina

Open source

DOI
10.1186/s12913-026-15139-0
Published
2026-08-03
Container
BMC Health Services Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12913-026-15139-0,
  title = {Cost-utility of respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for disease prevention among colombian infants},
  author = {Jaime Ordóñez and Beatriz Ospina},
  year = {2026},
  journal = {BMC Health Services Research},
  doi = {10.1186/s12913-026-15139-0},
  url = {https://doi.org/10.1186/s12913-026-15139-0}
}

RIS

TY  - JOUR
TI  - Cost-utility of respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for disease prevention among colombian infants
AU  - Jaime Ordóñez
AU  - Beatriz Ospina
PY  - 2026
JO  - BMC Health Services Research
DO  - 10.1186/s12913-026-15139-0
UR  - https://doi.org/10.1186/s12913-026-15139-0
ER  - 

APA

Ordóñez, J., & Ospina, B. (2026). Cost-utility of respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for disease prevention among colombian infants. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15139-0

Source records